| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/20/2008 | US7375227 May be combined with ACE inhibitors, angiotensin or endothelin receptor antagonists, vasopressin antagonists, alpha- and beta-adrenergic antagonists, TNFalpha antagonists, and peroxisome proliferator activator receptor modulators; cardiovascular, renal, metabolic, pulmonary and psychological disorders |
| 05/20/2008 | US7375218 highly convergent and this convergency manifests itself in a much shorter synthetic sequence |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2322309C Quinolin-4-yl derivatives |
| 05/15/2008 | WO2008058118A2 Preparation of montelukast and its salts |
| 05/15/2008 | WO2008056148A1 Chemical compounds |
| 05/15/2008 | WO2008023333A3 Process for the preparation of 4-(isobutylamino)-3-amino-quinoline |
| 05/15/2008 | WO2007138112A3 Compounds that interact with ion channels, in particular with ion channels from the kv family |
| 05/15/2008 | US20080113975 Thiourea compounds |
| 05/15/2008 | CA2669034A1 Chemical compounds |
| 05/14/2008 | EP1921062A2 Amino acid derivatives as HIV aspartyl protease inhibitors |
| 05/14/2008 | EP1919879A1 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 05/14/2008 | EP1919872A2 Chemical compounds |
| 05/14/2008 | EP1919871A2 Method for the synthesis of quinoli e derivatives |
| 05/14/2008 | EP1713776B1 Quinoline derivatives for use as mycobacterial inhibitors |
| 05/14/2008 | EP1711468B1 Process for preparing purified ciprofloxacin |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | CN101180302A Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 05/14/2008 | CN101180273A Methods of synthesizing 6-alkylaminoquinoline derivatives |
| 05/14/2008 | CN101180269A Method of preparing 3-cyano-quinolines and intermediates made thereby |
| 05/14/2008 | CN101177412A Method for synthesizing acetyl substituted nitrogen heterocycle compounds |
| 05/14/2008 | CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 05/14/2008 | CN100387576C Substituted phenylalkanoic acid derivatives and use thereof |
| 05/13/2008 | US7371868 Bactericides; 2-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-5-isoindolyl]-1,3,6,2-dioxazaborocane. |
| 05/13/2008 | US7371865 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371764 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 05/13/2008 | US7371752 such as 5-(4-Fluorophenyl)-7-[(2-pyridyl)-methyloxy]-thieno[3,2-b]pyridine, used as prodrugs or antagonists for GABA receptors, in diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and epileptic disorders, as cognition activators and as antidotes to benzodiazepines |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053158A1 Inhibitors of p38 mitogen-activated protein kinase |
| 05/08/2008 | WO2007028022A3 Novel compounds as p2x7 modulators and uses thereof |
| 05/08/2008 | US20080108656 3-Fluoro-2-(2-methylsulfanyl-phenyl)-quinolin-4-yl]-pyridin-4-yl-amine; modulating transforming growth factor (TGF) - beta; fibroproliferative diseases or diseases associated with fibrosis; cardiovascular, urogenital and gastrointestinal disorders; antihypotensive, -arthritic agents; angioplasty |
| 05/08/2008 | US20080108651 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108122 Microchemical nanofactories |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917245A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917244A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 05/07/2008 | EP1603880B1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 05/07/2008 | EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 05/07/2008 | CN101173058A Method for producing molecular engram polyalcohol microsphere and method for separating enrofloxacin thereof |
| 05/07/2008 | CN101172966A Method for producing aripiprazole crystallite |
| 05/07/2008 | CN100386318C Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 05/06/2008 | US7368592 Process for the preparation of alkyl n-alkylanthranilate |
| 05/06/2008 | US7368573 Triamide-substituted heterobicyclic compounds |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/02/2008 | WO2008049922A2 A new process for the preparation of montelukast |
| 05/02/2008 | CA2666539A1 Substituted phenylmethyl bicyclocarboxyamide compounds |
| 05/01/2008 | US20080103174 Ether derivatives |
| 05/01/2008 | US20080103173 Compounds Having Activity At Nk3 Receptor And Uses Thereof In Medicine |
| 05/01/2008 | US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 04/30/2008 | EP1915382A2 Hepatitis c serine protease inhibitors and uses therefor |
| 04/30/2008 | CN101171234A Dihydropyridine derivatives |
| 04/30/2008 | CN100384833C Therapeutic chroman compounds |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384824C Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/29/2008 | USRE40278 Heterocyclic amines having central nervous system activity |
| 04/29/2008 | US7365209 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 04/29/2008 | US7365203 Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/29/2008 | US7365081 Antitumor agents |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/24/2008 | WO2008049047A2 Quinoline compounds |
| 04/24/2008 | WO2008048698A2 Chemical switches for detecting reactive chemical agents |
| 04/24/2008 | WO2008046598A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/24/2008 | US20080097119 preventing, treating or ameliorating retinoid poisoning, overdose by a retinoid; Z-4-[3-(3,3-Dimethyl-1-p-tolyl-3H-inden-5-yl)-3-hydroxyimino-propenyl]-3-fluoro-benzoic acid |
| 04/24/2008 | US20080097104 Novel Compounds and Preparation for Montelukast Sodium |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096917 for plants; 2-(dibenzofuranyl-2-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(indanyl-5-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(3-phenylquinolinyl-6-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; phytopathogenic fungi |
| 04/24/2008 | US20080096894 Anti-Bacterial Compounds |
| 04/24/2008 | US20080096885 Methyl 1-(2-fluorophenyl)-2-[(3-methoxy-2-phenylquinolin-4-yl)carbonyl]hydrazinecarboxylate; schizophrenia |
| 04/24/2008 | US20080096884 phosphodiesterase inhibitors; inflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | US20080096873 New compounds |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | CA2672926A1 Bicyclic heteroaromatic compounds |
| 04/24/2008 | CA2666508A1 Quinoline compounds |
| 04/24/2008 | CA2665376A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 04/23/2008 | EP1914227A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912958A1 Substituted malononitrile compounds for combating animal pests |
| 04/23/2008 | EP1912948A1 Antibacterial quinoline derivatives |
| 04/23/2008 | EP1912648A2 Quinoline derivatives as antibacterial agents |
| 04/23/2008 | EP1912647A2 Quinoline derivatives as antibacterical agents |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | CN101166726A Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/22/2008 | US7361756 by mixing 7-hydroxy-tetrahydroquinolinone, dibromobutane, and at least one base to form a reaction mixture; using phase transfer catalysts; or using a low boiling point solvent |